These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1927485)

  • 1. Treatment of vestibular disorders.
    Itoh A; Sakata E
    Acta Otolaryngol Suppl; 1991; 481():617-23. PubMed ID: 1927485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labyrinth anesthesia--a forgotten but practical treatment option in Ménière's disease.
    Adunka O; Moustaklis E; Weber A; May A; von Ilberg C; Gstoettner W; Kierner AC
    ORL J Otorhinolaryngol Relat Spec; 2003; 65(2):84-90. PubMed ID: 12824729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intratympanic corticosteroid perfusion in the therapy of Meniere's disease].
    Sanković-Babić S; Kosanović R; Ivanković Z; Babac S; Tatović M
    Srp Arh Celok Lek; 2014; 142(5-6):291-5. PubMed ID: 25033583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
    Silverstein H; Isaacson JE; Olds MJ; Rowan PT; Rosenberg S
    Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
    Weckel A; Marx M; Esteve-Fraysse MJ
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic steroids for Ménière's disease or syndrome.
    Phillips JS; Westerberg B
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008514. PubMed ID: 21735432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere's Disease Patients.
    Atrache Al Attrache N; Krstulovic C; Pérez Guillen V; Morera Pérez C; Pérez Garrigues H
    J Int Adv Otol; 2016 Apr; 12(1):92-7. PubMed ID: 27340991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report).
    Silverstein H; Choo D; Rosenberg SI; Kuhn J; Seidman M; Stein I
    Ear Nose Throat J; 1996 Aug; 75(8):468-71, 474, 476 passim. PubMed ID: 8828271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenotomy of the middle ear muscles causes a dramatic reduction in vertigo attacks and improves audiological function in definite Meniere's disease.
    Loader B; Beicht D; Hamzavi JS; Franz P
    Acta Otolaryngol; 2012 May; 132(5):491-7. PubMed ID: 22201453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Diagnosis and Management of Acute Vertigo from Vestibular Migraine and Ménière's Disease.
    Seemungal B; Kaski D; Lopez-Escamez JA
    Neurol Clin; 2015 Aug; 33(3):619-28, ix. PubMed ID: 26231275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vestibular neurectomy vs. chemical labyrinthectomy in the treatment of disabling Menière's disease: a long-term comparative study.
    Schmerber S; Dumas G; Morel N; Chahine K; Karkas A
    Auris Nasus Larynx; 2009 Aug; 36(4):400-5. PubMed ID: 19026499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intratympanic dexamethasone injections for intractable Meniere's disease].
    Lu Y; Ren J; Wu W; Yin T; Yang X; Xie D
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):385-7. PubMed ID: 15499973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide.
    Yamazaki T; Hayashi M; Komatsuzaki A
    Acta Otolaryngol Suppl; 1991; 481():613-6. PubMed ID: 1927484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic steroid injections for intractable Ménière's disease.
    Barrs DM; Keyser JS; Stallworth C; McElveen JT
    Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intratympanic dexamethasone injections for intractable Meniere's disease].
    Huang Y; She Y; Li W; Cheng C
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Aug; 19(16):748-9. PubMed ID: 16320717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DECOMPRESSION OF THE LABYRINTH. A NEW SURGICAL PROCEDURE FOR MENIERE'S DISEASE.
    VAN FICKI
    Arch Otolaryngol; 1964 May; 79():447-58. PubMed ID: 14120668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.